Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
Lola Sepot-Boucherit, Director Rare Bleeding Disorders at Novo Nordisk, shared a post on LinkedIn:
“Under brilliant Parisian sunshine, the City of Light became a catalyst for scientific exchange, collaboration and innovation at ISTH.
It was a privilege to welcome the global haemostasis community to France and to engage with researchers and healthcare professionals from around the world. Throughout the week, the science on display highlighted how rapidly our field is evolving.
For Novo Nordisk, the congress of the International Society on Thrombosis and Haemostasis (ISTH) also reflected the exciting new chapter we are entering in rare diseases.
As we accelerate research and scientific innovation, the engagement of our Executive Management, including Hong Chow, reinforced our long-term commitment and ambition to help reimagine the future of care for people living with rare bleeding disorders.
It was also a real pleasure to welcome so many Novo Nordisk colleagues to Paris, share a little of the French art de vivre, and spend this memorable week alongside our amazing French team.
See you next year in Vancouver!”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question